title: Antidepressants stimulate hippocampal neurogenesis by inhibiting p21 expression in the subgranular zone of the hipppocampus.
abstract: The relationships among hippocampal neurogenesis, depression and the mechanism of action of antidepressant drugs have generated a considerable amount of controversy. The cyclin-dependent kinase (Cdk) inhibitor p21(Cip1) (p21) plays a crucial role in restraining cellular proliferation and maintaining cellular quiescence. Using in vivo and in vitro approaches the present study shows that p21 is expressed in the subgranular zone of the dentate gyrus of the hippocampus in early neuronal progenitors and in immature neurons, but not in mature neurons or astroglia. In vitro, proliferation is higher in neuronal progenitor cells derived from p21-/- mice compared to cells derived from wild-type mice. Proliferation is increased in neuronal progenitor cells after suppression of p21 using lentivirus expressing short hairpin RNA against p21. In vivo, chronic treatment with the non-selective antidepressant imipramine as well as the norepinephrine-selective reuptake inhibitor desipramine or the serotonin-selective reuptake inhibitor fluoxetine all decrease p21 expression, and this was associated with increased neurogenesis. Chronic antidepressant treatment did not affect the expression of other Cdk inhibitors. Untreated p21-/- mice exhibit a higher degree of baseline neurogenesis and decreased immobility in the forced swim test. Although chronic imipramine treatment increased neurogenesis and reduced immobility in the forced swim test in wild-type mice, it reduced neurogenesis and increased immobility in p21-/- mice. These results demonstrate the unique role of p21 in the control of neurogenesis, and support the hypothesis that different classes of reuptake inhibitor-type antidepressant drugs all stimulate hippocampal neurogenesis by inhibiting p21 expression.
authors.affiliation: Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America.
authors.forename: Robert N
authors.initials: RN
authors.lastname: Pechnick
authors.forename: Svetlana
authors.initials: S
authors.lastname: Zonis
authors.forename: Kolja
authors.initials: K
authors.lastname: Wawrowsky
authors.forename: Rosemarie
authors.initials: R
authors.lastname: Cosgayon
authors.forename: Catherine
authors.initials: C
authors.lastname: Farrokhi
authors.forename: Liliana
authors.initials: L
authors.lastname: Lacayo
authors.forename: Vera
authors.initials: V
authors.lastname: Chesnokova
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D015153:Blotting, Western; D049109:Cell Proliferation / Q000187:drug effects; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000037:antagonists & inhibitors / Q000502:physiology*; D003863:Depression / Q000188:drug therapy; D005260:Female; D005473:Fluoxetine / Q000494:pharmacology; D006624:Hippocampus / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D007099:Imipramine / Q000494:pharmacology; D007124:Immunoenzyme Techniques; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009474:Neurons / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology; D013234:Stem Cells / Q000187:drug effects*; D013550:Swimming
chemical_list: D000928:Antidepressive Agents; D050759:Cyclin-Dependent Kinase Inhibitor p21; D005473:Fluoxetine; D007099:Imipramine; D034741:RNA, Small Interfering; D017367:Selective Serotonin Reuptake Inhibitors; C493957:Cdkn1a protein, mouse
references.citation: Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7925-30
references.pmid: 12792021
references.citation: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8233-8
references.pmid: 16702546
references.citation: Cell Stem Cell. 2011 May 6;8(5):566-79
references.pmid: 21549330
references.citation: J Clin Invest. 2004 Jan;113(2):160-8
references.pmid: 14722605
references.citation: Science. 1992 Mar 27;255(5052):1707-10
references.pmid: 1553558
references.citation: Mol Cell Biol. 2010 Jul;30(14):3685-94
references.pmid: 20479122
references.citation: Development. 2005 Jul;132(14):3231-42
references.pmid: 15958511
references.citation: Neuron. 1994 Nov;13(5):1071-82
references.pmid: 7946346
references.citation: Proc Natl Acad Sci U S A. 2006 Nov 14;103(46):17501-6
references.pmid: 17088541
references.citation: Cancer Res. 2005 May 15;65(10):3980-5
references.pmid: 15899785
references.citation: Neuropsychopharmacology. 2004 Apr;29(4):770-6
references.pmid: 14970834
references.citation: Front Biosci. 1998 Apr 06;3:d419-30
references.pmid: 9545437
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):739-59
references.pmid: 15925699
references.citation: J Neurosci. 2000 Dec 15;20(24):9104-10
references.pmid: 11124987
references.citation: J Biochem Mol Toxicol. 1999;13(6):338-47
references.pmid: 10487422
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1358-63
references.pmid: 18172194
references.citation: Science. 2007 Aug 10;317(5839):819-23
references.pmid: 17615305
references.citation: Drug Chem Toxicol. 2005;28(1):117-33
references.pmid: 15720040
references.citation: Psychopharmacology (Berl). 1988;94(2):147-60
references.pmid: 3127840
references.citation: J Neurosci. 2008 Feb 6;28(6):1374-84
references.pmid: 18256257
references.citation: Psychopharmacology (Berl). 2001 Jan;153(3):395-8
references.pmid: 11271414
references.citation: J Neurosci. 1999 Dec 1;19(23):10494-501
references.pmid: 10575045
references.citation: Mol Psychiatry. 2002;7 Suppl 1:S23-8
references.pmid: 11986992
references.citation: Neurosci Biobehav Rev. 2005;29(4-5):547-69
references.pmid: 15893822
references.citation: Psychopharmacology (Berl). 2006 Mar;185(1):76-83
references.pmid: 16416158
references.citation: Genes Dev. 2005 Mar 15;19(6):756-67
references.pmid: 15769947
references.citation: Cell. 2004 Jan 23;116(2 Suppl):S57-9, 2 p following S59
references.pmid: 15055583
references.citation: Hum Mol Genet. 2001 Apr;10(7):699-703
references.pmid: 11257102
references.citation: Neurosci Lett. 2000 Sep 8;291(1):17-20
references.pmid: 10962143
references.citation: Mol Endocrinol. 2005 Sep;19(9):2371-9
references.pmid: 15919720
references.citation: Nature. 1995 Mar 9;374(6518):131-4
references.pmid: 7877684
references.citation: Nature. 2011 Aug 03;476(7361):458-61
references.pmid: 21814201
references.citation: Development. 2003 Jan;130(2):391-9
references.pmid: 12466205
references.citation: Oncogene. 1999 Feb 4;18(5):1239-44
references.pmid: 10022130
references.citation: Nat Neurosci. 2003 Nov;6(11):1127-34
references.pmid: 14583753
references.citation: J Psychiatry Neurosci. 2004 May;29(3):196-205
references.pmid: 15173896
references.citation: Physiol Rev. 2005 Apr;85(2):523-69
references.pmid: 15788705
references.citation: Neuron. 2008 Oct 9;60(1):149-61
references.pmid: 18940595
references.citation: Science. 2000 Feb 25;287(5457):1433-8
references.pmid: 10688783
references.citation: Prog Mol Subcell Biol. 1998;20:43-71
references.pmid: 9928526
references.citation: Cell Stem Cell. 2010 Oct 8;7(4):483-95
references.pmid: 20887954
references.citation: J Biol Chem. 1999 Mar 5;274(10):6039-42
references.pmid: 10037682
references.citation: Biol Psychiatry. 2004 Aug 1;56(3):140-5
references.pmid: 15271581
references.citation: Science. 2003 Aug 8;301(5634):805-9
references.pmid: 12907793